National Cancer Institute, Naples: Breast Neoplasms trials

The registry lists 11 Breast Neoplasms studies with National Cancer Institute, Naples as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 2 4Phase 3 4No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Financial Toxicity in Patients With Early-stage Breast CancerRecruitingNCT07354165
• Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.RecruitingNCT05817227
• The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical.Active, not recruitingNCT06866093
• Diet, Exercise and Vitamin D in Breast Cancer RecurrenceStatus unknownNCT02786875Phase 3
• ELBA: Exemestane and Lapatinib in Advanced Breast CancerWithdrawnNCT01005641Phase 2
• BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast CancerCompletedNCT00540800Phase 3
• CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast CancerWithdrawnNCT00434031Phase 2
• VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast CancerStatus unknownNCT00431704Phase 2
• HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.Active, not recruitingNCT00412022Phase 3
• HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast CancerCompletedNCT00401427Phase 2
• ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant TreatmentCompletedNCT00331097Phase 3